These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 8144582)
1. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Yan SD; Schmidt AM; Anderson GM; Zhang J; Brett J; Zou YS; Pinsky D; Stern D J Biol Chem; 1994 Apr; 269(13):9889-97. PubMed ID: 8144582 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654 [TBL] [Abstract][Full Text] [Related]
3. RAGE: a novel cellular receptor for advanced glycation end products. Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899 [TBL] [Abstract][Full Text] [Related]
4. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. Schmidt AM; Mora R; Cao R; Yan SD; Brett J; Ramakrishnan R; Tsang TC; Simionescu M; Stern D J Biol Chem; 1994 Apr; 269(13):9882-8. PubMed ID: 8144581 [TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. Schmidt AM; Weidman E; Lalla E; Yan SD; Hori O; Cao R; Brett JG; Lamster IB J Periodontal Res; 1996 Oct; 31(7):508-15. PubMed ID: 8915955 [TBL] [Abstract][Full Text] [Related]
6. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Schmidt AM; Hori O; Brett J; Yan SD; Wautier JL; Stern D Arterioscler Thromb; 1994 Oct; 14(10):1521-8. PubMed ID: 7918300 [TBL] [Abstract][Full Text] [Related]
7. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. Tanaka N; Yonekura H; Yamagishi S; Fujimori H; Yamamoto Y; Yamamoto H J Biol Chem; 2000 Aug; 275(33):25781-90. PubMed ID: 10829018 [TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Schmidt AM; Hasu M; Popov D; Zhang JH; Chen J; Yan SD; Brett J; Cao R; Kuwabara K; Costache G Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8807-11. PubMed ID: 8090728 [TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Bierhaus A; Illmer T; Kasper M; Luther T; Quehenberger P; Tritschler H; Wahl P; Ziegler R; Müller M; Nawroth PP Circulation; 1997 Oct; 96(7):2262-71. PubMed ID: 9337199 [TBL] [Abstract][Full Text] [Related]
10. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443 [TBL] [Abstract][Full Text] [Related]
11. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300 [TBL] [Abstract][Full Text] [Related]
12. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Schmidt AM; Yan SD; Wautier JL; Stern D Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470 [TBL] [Abstract][Full Text] [Related]
13. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201 [TBL] [Abstract][Full Text] [Related]
14. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063 [TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway. Lu M; Xu L; Li B; Zhang W; Zhang C; Feng H; Cui X; Gao H J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):87-97. PubMed ID: 20495289 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Kaji Y; Amano S; Usui T; Oshika T; Yamashiro K; Ishida S; Suzuki K; Tanaka S; Adamis AP; Nagai R; Horiuchi S Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):521-8. PubMed ID: 12556378 [TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047 [TBL] [Abstract][Full Text] [Related]
19. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Bonnardel-Phu E; Wautier JL; Schmidt AM; Avila C; Vicaut E Diabetes; 1999 Oct; 48(10):2052-8. PubMed ID: 10512373 [TBL] [Abstract][Full Text] [Related]
20. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]